NUGL Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUGL research report →
Companywww.nugl.com
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America.
- CEO
- Balram Vaswani
- IPO
- 2002
- Employees
- 12
- HQ
- Chino, CA, US
Price Chart
Valuation
- Market Cap
- $1.69M
- P/E
- -1.88
- P/S
- 0.66
- P/B
- 1.45
- EV/EBITDA
- -8.87
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 45.03%
- Op Margin
- -18.80%
- Net Margin
- -41.67%
- ROE
- -65.17%
- ROIC
- -16.20%
Growth & Income
- Revenue
- $2.97M · 27.43%
- Net Income
- $-212,000 · 74.43%
- EPS
- $-0.00 · 77.78%
- Op Income
- $-582,000
- FCF YoY
- -118.31%
Performance & Tape
- 52W High
- $0.01
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.54
- Avg Volume
- 1.44M
Get TickerSpark's AI analysis on NUGL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NUGL Coverage
We haven't published any research on NUGL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NUGL Report →